136 related articles for article (PubMed ID: 20980149)
1. SATB1 gene expression and breast cancer prognosis.
Hanker LC; Karn T; Mavrova-Risteska L; Ruckhäberle E; Gaetje R; Holtrich U; Kaufmann M; Rody A; Wiegratz I
Breast; 2011 Aug; 20(4):309-13. PubMed ID: 20980149
[TBL] [Abstract][Full Text] [Related]
2. Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer.
Rody A; Karn T; Ruckhäberle E; Müller V; Gehrmann M; Solbach C; Ahr A; Gätje R; Holtrich U; Kaufmann M
Breast Cancer Res Treat; 2009 Feb; 113(3):457-66. PubMed ID: 18340528
[TBL] [Abstract][Full Text] [Related]
3. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
4. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
[TBL] [Abstract][Full Text] [Related]
5. The role of SATB1 in breast cancer pathogenesis.
Iorns E; Hnatyszyn HJ; Seo P; Clarke J; Ward T; Lippman M
J Natl Cancer Inst; 2010 Aug; 102(16):1284-96. PubMed ID: 20595686
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.
Nagpal N; Ahmad HM; Molparia B; Kulshreshtha R
Carcinogenesis; 2013 Aug; 34(8):1889-99. PubMed ID: 23542418
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL
Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745
[TBL] [Abstract][Full Text] [Related]
9. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
10. Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1.
Rody A; Holtrich U; Gaetje R; Gehrmann M; Engels K; von Minckwitz G; Loibl S; Diallo-Danebrock R; Ruckhäberle E; Metzler D; Ahr A; Solbach C; Karn T; Kaufmann M
Clin Cancer Res; 2007 Feb; 13(4):1115-22. PubMed ID: 17317819
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
12. Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers.
Coutant C; Rouzier R; Qi Y; Lehmann-Che J; Bianchini G; Iwamoto T; Hortobagyi GN; Symmans WF; Uzan S; Andre F; de Thé H; Pusztai L
Clin Cancer Res; 2011 Apr; 17(8):2591-601. PubMed ID: 21248301
[TBL] [Abstract][Full Text] [Related]
13. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.
Voduc D; Cheang M; Nielsen T
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):365-73. PubMed ID: 18268121
[TBL] [Abstract][Full Text] [Related]
14. Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.
Rody A; Karn T; Ruckhäberle E; Hanker L; Metzler D; Müller V; Solbach C; Ahr A; Gätje R; Holtrich U; Kaufmann M
Eur J Cancer; 2009 Feb; 45(3):405-13. PubMed ID: 19054665
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
16. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of the putative stem cell marker p63 in breast cancer.
Hanker L; Karn T; Ruckhaeberle E; Gaetje R; Solbach C; Schmidt M; Engels K; Holtrich U; Kaufmann M; Rody A
Breast Cancer Res Treat; 2010 Aug; 122(3):765-75. PubMed ID: 19898932
[TBL] [Abstract][Full Text] [Related]
18. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
19. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
[TBL] [Abstract][Full Text] [Related]
20. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.
Freund A; Chauveau C; Brouillet JP; Lucas A; Lacroix M; Licznar A; Vignon F; Lazennec G
Oncogene; 2003 Jan; 22(2):256-65. PubMed ID: 12527894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
